Unknown

Dataset Information

0

Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.


ABSTRACT: Foxp3(+) T-regulatory cells (Tregs) are key to immune homeostasis such that their diminished numbers or function can cause autoimmunity and allograft rejection. Foxp3(+) Tregs express multiple histone/protein deacetylases (HDACs) that regulate chromatin remodeling, gene expression, and protein function. Pan-HDAC inhibitors developed for oncologic applications enhance Treg production and Treg suppression function but have limited nononcologic utility given their broad actions and various side effects. We show, using HDAC6-deficient mice and wild-type (WT) mice treated with HDAC6-specific inhibitors, that HDAC6 inhibition promotes Treg suppressive activity in models of inflammation and autoimmunity, including multiple forms of experimental colitis and fully major histocompatibility complex (MHC)-incompatible cardiac allograft rejection. Many of the beneficial effects of HDAC6 targeting are also achieved by inhibition of the HDAC6-regulated protein heat shock protein 90 (HSP90). Hence, selective targeting of a single HDAC isoform, HDAC6, or its downstream target, HSP90, can promote Treg-dependent suppression of autoimmunity and transplant rejection.

SUBMITTER: de Zoeten EF 

PROVIDER: S-EPMC3133361 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.

de Zoeten Edwin F EF   Wang Liqing L   Butler Kyle K   Beier Ulf H UH   Akimova Tatiana T   Sai Hong H   Bradner James E JE   Mazitschek Ralph R   Kozikowski Alan P AP   Matthias Patrick P   Hancock Wayne W WW  

Molecular and cellular biology 20110328 10


Foxp3(+) T-regulatory cells (Tregs) are key to immune homeostasis such that their diminished numbers or function can cause autoimmunity and allograft rejection. Foxp3(+) Tregs express multiple histone/protein deacetylases (HDACs) that regulate chromatin remodeling, gene expression, and protein function. Pan-HDAC inhibitors developed for oncologic applications enhance Treg production and Treg suppression function but have limited nononcologic utility given their broad actions and various side eff  ...[more]

Similar Datasets

| S-EPMC7254527 | biostudies-literature
| S-EPMC10811298 | biostudies-literature
| S-EPMC2917523 | biostudies-literature
| S-EPMC4563765 | biostudies-literature
| S-EPMC4813586 | biostudies-literature
| S-EPMC4362235 | biostudies-other
| S-EPMC3663493 | biostudies-literature
| S-EPMC6172049 | biostudies-literature
| S-EPMC4602144 | biostudies-literature
| S-EPMC1895907 | biostudies-literature